Psynerva Pharmaceuticals Private Limited
About Psynerva Pharmaceuticals Private Limited
Data last updated:
Psynerva Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 26 December 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24232BR2013PTC021713. Its GSTIN is 10AAHCP5536E1ZS (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8 Lakh. It is led by directors Archana Saurav and Prasanna Jee Sahay.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Shri Onkar Nath Sahay Hari Om Sadan Road No – 3 B R.M.S Colony Kankarbagh, Patna, Bihar, India – 800020.
As per the financials filed for FY 2024, the company reported a revenue of ₹9.88 Lakh, a growth of 52% compared to the previous year. For the same year it recorded a net profit of ₹51,491 (net margin 5.2%) and EBITDA of ₹65,087 (EBITDA margin 6.6%). Revenue has declined at a compounded annual rate (CAGR) of 21% over three years and 4% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O Shri Onkar Nath Sahay Hari Om Sadan Road No – 3 B R.M.S Colony Kankarbagh, Patna, Bihar, India – 800020
- IndustryTrading, Other Wholesale, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Psynerva Pharmaceuticals Private Limited
The main business activity of Psynerva Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Psynerva Pharmaceuticals Private Limited FY 2025 filings available
Psynerva Pharmaceuticals Private Limited reported revenue of ₹9.88 Lakh (up 52% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Psynerva Pharmaceuticals Private Limited
Revenue rose 52% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 4%. EBITDA rose 90% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Psynerva Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹65,087 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹51,491 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Psynerva Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 5.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Psynerva Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Psynerva Pharmaceuticals Private Limited
Psynerva Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Archana Saurav | Director | 08 Feb 2021 | 5 Years 8 Months | Current |
| Prasanna Jee Sahay | Director | 26 Dec 2013 | 12 Years 9 Months | Current |
Peer Comparison of Psynerva Pharmaceuticals Private Limited
Psynerva Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ribston Pharmaceuticals Private Limited | ₹9.93 Lakh (FY 2025) | •••• | •••• | 11.0% | •••• | New Delhi, Delhi, India |
| Reydis Pharmaceuticals Private Limited | ₹9.93 Lakh (FY 2025) | •••• | •••• | •••• | Tijara, Rajasthan, India | |
| Aquiluna Pharmaceuticals Private Limited | ₹9.91 Lakh (FY 2024) | •••• | •••• | 1414.0% | •••• | Kanpur, Uttar Pradesh, India |
| Ricrisa Pharmaceuticals Private Limited | ₹9.91 Lakh (FY 2025) | •••• | •••• | 43.0% | •••• | Nagpur, Maharashtra, India |
| Columbine Pharmaceuticals Private Limited | ₹9.9 Lakh (FY 2024) | •••• | •••• | 277.0% | •••• | Burdwan, West Bengal, India |
| Psynerva Pharmaceuticals Private Limited this company | ₹9.88 Lakh (FY 2024) | •••• | •••• | 52.0% | •••• | Patna, Bihar, India |
| Unistretch Pharmaceuticals Private Limited | ₹9.87 Lakh (FY 2021) | •••• | •••• | 62.0% | •••• | Gulbarga, Karnataka, India |
| Bryopetris Pharmaceuticals Private Limited | ₹9.86 Lakh (FY 2025) | •••• | •••• | 1.0% | •••• | Indore, Madhya Pradesh, India |
| Nugenesys Pharmaceuticals Private Limited | ₹9.85 Lakh (FY 2025) | •••• | •••• | •••• | Thane, Maharashtra, India | |
| Syan Pharmaceuticals Private Limited | ₹9.81 Lakh (FY 2024) | •••• | •••• | -18.0% | •••• | Jehanabad, Bihar, India |
| Maclave Pharmaceuticals Private Limited | ₹9.78 Lakh (FY 2024) | •••• | •••• | 24.0% | •••• | Etawah, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Psynerva Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Psynerva Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Psynerva Pharmaceuticals Private Limited
Psynerva Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Psynerva Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Psynerva Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Psynerva Pharmaceuticals Private Limited
Psynerva Pharmaceuticals Private Limited has 5 board changes on record since 2013: 2 appointments and 3 cessations. The latest: Mukundjee Sahay ceased to be Director on 22 Aug 2024.
Credit Ratings, Litigation & Regulatory Alerts for Psynerva Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Psynerva Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Psynerva Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Psynerva Pharmaceuticals Private Limited
Psynerva Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAHCP5536E1ZS | Bihar | Active | 13 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Psynerva Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Psynerva Pharmaceuticals Private Limited
Psynerva Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in other wholesale, within the trading industry. It was incorporated on 26 December 2013 (13+ years old) and is registered under CIN U24232BR2013PTC021713.
Psynerva Pharmaceuticals reported revenue of ₹9.88 Lakh for FY 2024 (up 52% YoY).
Psynerva Pharmaceuticals has 2 current directors:
- Archana Saurav - Director
- Prasanna Jee Sahay - Director
Psynerva Pharmaceuticals reported a net profit of ₹51,491 (net margin 5.2%) and EBITDA of ₹65,087 (EBITDA margin 6.6%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Psynerva Pharmaceuticals is 21% over three years and -4% over five years. In the latest year (FY 2024) revenue rose 52%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Psynerva Pharmaceuticals is 10AAHCP5536E1ZS, registered in Bihar.
The CIN (Corporate Identification Number) of Psynerva Pharmaceuticals is U24232BR2013PTC021713. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Psynerva Pharmaceuticals was incorporated on 26 December 2013, making it 13+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Psynerva Pharmaceuticals by revenue are Ribston Pharmaceuticals Private Limited, Reydis Pharmaceuticals Private Limited, Aquiluna Pharmaceuticals Private Limited, Ricrisa Pharmaceuticals Private Limited, Columbine Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Mukundjee Sahay ceased to be Director on 22 Aug 2024. Rohit ceased to be Director on 24 Feb 2021. Archana Saurav was appointed as Director on 08 Feb 2021. Psynerva Pharmaceuticals has 5 board changes on record in total.
The registered office of Psynerva Pharmaceuticals is at CO Shri Onkar Nath Sahay Hari Om Sadan Road No – 3 B R.M.S Colony Kankarbagh, Patna, Bihar, India – 800020.